At a meeting of the SNBTS Medical and Scientific Committee Dr Urbaniak asked what should be said to a Hepatitis C positive donor who asked about his previous donations. It was noted that it had previously been agreed that there would be no lookback "and this should be conveyed to the donor." Read more about At a meeting of the SNBTS Medical and Scientific Committee Dr Urbaniak asked what should be said to a Hepatitis C positive donor who asked about his previous donations. It was noted that it had previously been agreed that there would be no lookback "and this should be conveyed to the donor."
The Deputy Chief Medical Officer, Dr Jeremy Metters wrote to Professor Cash to advise the next ACVSB meeting was postponed so its members could further consider advice provided recently. Read more about The Deputy Chief Medical Officer, Dr Jeremy Metters wrote to Professor Cash to advise the next ACVSB meeting was postponed so its members could further consider advice provided recently.
Professor Cash wrote to Dr Jack Gillon to advise the commencement of anti-HCV donation screening, with a high priority for producing operation guidelines for counselling anti-HCV confirmed positive donors Read more about Professor Cash wrote to Dr Jack Gillon to advise the commencement of anti-HCV donation screening, with a high priority for producing operation guidelines for counselling anti-HCV confirmed positive donors
Professor Cash wrote to Dr Jack Gillon to discuss the Medical & Scientific Committee agreement to use donor counselling guidelines in leaflet form within RTCs. Read more about Professor Cash wrote to Dr Jack Gillon to discuss the Medical & Scientific Committee agreement to use donor counselling guidelines in leaflet form within RTCs.
Dr Keel wrote to Professor Franklin to discuss the HCV lookback exercise in 1998, and noted it could not be considered formally closed until reasons for non-traceability of components or recipients were logged on the lookback register. Read more about Dr Keel wrote to Professor Franklin to discuss the HCV lookback exercise in 1998, and noted it could not be considered formally closed until reasons for non-traceability of components or recipients were logged on the lookback register.
In a letter to Professor Cash, Dr Gunson noted the RTCs did not have access to anti-HCV testing material, and recommended usual investigations in reported cases involving a transfusion-associated NANBH. Read more about In a letter to Professor Cash, Dr Gunson noted the RTCs did not have access to anti-HCV testing material, and recommended usual investigations in reported cases involving a transfusion-associated NANBH.
In a letter to Dr Gunson, Professor Cash proposed delaying any lookback programme until further UK deliberations had taken place. Read more about In a letter to Dr Gunson, Professor Cash proposed delaying any lookback programme until further UK deliberations had taken place.
At a meeting, Dr Gillon briefed the SNBTS Medical and Scientific Committee on the Hepatitis C lookback. Read more about At a meeting, Dr Gillon briefed the SNBTS Medical and Scientific Committee on the Hepatitis C lookback.
At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented the SACTTI's paper on Hepatitis C Lookback. Professor Arie Zuckerman raised concerns that interferon was not licensed for treatment of Hepatitis C-related disease and ribavirin was noted to be "even more costly." Read more about At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented the SACTTI's paper on Hepatitis C Lookback. Professor Arie Zuckerman raised concerns that interferon was not licensed for treatment of Hepatitis C-related disease and ribavirin was noted to be "even more costly."
At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented a report on the HCV lookback. Read more about At a meeting of the Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation Dr Robinson presented a report on the HCV lookback.